Welcome to our dedicated page for CaliberCos SEC filings (Ticker: CWD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on CaliberCos's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into CaliberCos's regulatory disclosures and financial reporting.
CaliberCos Inc. (CWD) filed a Form 4 on 20 June 2025 disclosing a routine equity compensation transaction for director Michael Trzupek. On 17 June 2025 the director received 5,052 employee stock options under the company’s 2024 Equity Incentive Plan.
- Exercise price: $3.55 per share
- Date exercisable: 17 June 2025 (immediate vesting indicated by same grant and exercisable date)
- Expiration: 17 June 2035 (10-year term)
- Securities underlying option: Class A common stock
- Post-grant holdings: 15,567 derivative securities (options) reported as beneficially owned; no common-share transactions reported in Table I
- Ownership nature: Direct
No sale of shares, change in ownership structure, or other derivative activity was reported. The filing merely documents an annual director compensation grant; therefore, it does not indicate any change in insider sentiment or company fundamentals. Investors typically view such issuances as non-dilutive in the short term because they are contingent on exercise at a premium to the current share price.
Form 4 snapshot – CaliberCos Inc. (CWD)
Director Lawrence X. Taylor III reported an option grant on 17 June 2025 under the company’s 2024 Equity Incentive Plan. The filing discloses the acquisition of 5,052 employee stock options with an exercise price of $3.55 per share and an expiration date of 17 June 2035. The options were acquired as part of normal board compensation; no shares were sold.
Following the transaction, Taylor directly holds 14,821 derivative securities linked to CWD Class A common stock. No non-derivative share transactions were reported. The filing does not reference any Rule 10b5-1 trading plan and does not alter Taylor’s status as a company director.
Because the transaction is a routine equity incentive grant with a modest size relative to CaliberCos’ public float, market impact is expected to be immaterial.
CaliberCos Inc. (CWD) – Form 4 insider filing
Director Daniel Paul Hansen reported one transaction dated June 17, 2025. The company granted him 5,052 employee stock options under the 2024 Equity Incentive Plan. The options carry an exercise price of $3.55 per share and expire on June 17, 2035.
Following this grant, Hansen beneficially owns 14,823 derivative securities (options) related to CaliberCos Class A common stock. The filing lists ownership as direct; no indirect holdings or sales were disclosed, and no non-derivative share transactions were reported.
The Form 4 indicates routine director compensation rather than an open-market purchase or sale. No Rule 10b5-1 trading plan was marked, and there were no amendments to prior filings.